BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
83 hedge funds and large institutions have $411M invested in bluebird bio in 2014 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 39 increasing their positions, 17 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
78% less call options, than puts
Call options by funds: $20K | Put options by funds: $91K
Holders
83
Holding in Top 10
1
Calls
$20K
Puts
$91K
Top Buyers
| 1 | +$11.4M | |
| 2 | +$7.91M | |
| 3 | +$6.57M | |
| 4 |
Millennium Management
New York
|
+$5.2M |
| 5 |
QF
QVT Financial
New York
|
+$4.48M |
Top Sellers
| 1 | -$20.4M | |
| 2 | -$6.94M | |
| 3 | -$5.17M | |
| 4 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$3.46M |
| 5 |
PC
PointState Capital
New York
|
-$2.1M |